US Ankylosing Spondylitis Market Highlights 2015 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/tm884s/us_ankylosing) has announced the addition of the "US Ankylosing Spondylitis Market Highlights - 2015" report to their offering.

The latest research, 'US Ankylosing Spondylitis Market Highlights - 2015', provides the US ankylosing spondylitis market analysis, competitive landscape, and ankylosing spondylitis drug sales forecast in the US.

The research includes the US ankylosing spondylitis market size estimates for 2014, market share forecast for six years to 2020, ankylosing spondylitis drugs market share, ankylosing spondylitis drugs sales estimates, ankylosing spondylitis drugs sales forecast, and ankylosing spondylitis late stage pipeline products.

The research helps executives track competitor drugs sales and market share in the US ankylosing spondylitis market. It supports decision making in R&D to long term marketing strategies. The report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in the US ankylosing spondylitis market.

Scope of the Report

- What are the drugs marketed in the US for treating ankylosing spondylitis?

Identify drugs marketed in the US for treating ankylosing spondylitis including trade name, molecule name, and company.

- How big is the US ankylosing spondylitis market?

Find out estimates for the US ankylosing spondylitis market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate country and indication level valuation of products and the market.

- What is my competitor's drugs market share in the US ankylosing spondylitis market?

You will know the market share of leading ankylosing spondylitis brands in the US, including generics share.

- What are the key molecules in pipeline for ankylosing spondylitis?

Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of ankylosing spondylitis. Our coverage includes molecule, mechanism of action, and the company.

- What is the future of the US ankylosing spondylitis market?

Gain insights into how the US ankylosing spondylitis market will advance along with market forecast till 2020.

- Future ankylosing spondylitis drugs forecast in the US

Find out how ankylosing spondylitis drugs will be positioned in the US in 2020, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.

Highlights of the Research:

- Marketed Ankylosing Spondylitis Drugs in the US

- The US Ankylosing Spondylitis Market Analysis

- Ankylosing Spondylitis Drugs Sales Analysis in the US

- Competitive Landscape in the US Ankylosing Spondylitis market

- Ankylosing Spondylitis Late Stage Pipeline

- The US Ankylosing Spondylitis Market Forecast

- Ankylosing Spondylitis Drugs Sales Forecast in the US

- Future Competitive Landscape

For more information visit http://www.researchandmarkets.com/research/tm884s/us_ankylosing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals